To study the outcome of inpatient rehabilitation in multiple sclerosis (MS), we conducted retrospective chart review and follow-up telephone interviews (six to thirty-six months after discharge) with thirty-seven consecutive MS patients admitted for rehabilitation following functional decline related to disease activity, trauma, or surgery. Functional Independence Measure (FIM), Kurtzke Functional Systems (FS), and Expanded Disability Status Scale (EDSS) scores at admission, discharge, and followup were analyzed. Of the thirty-seven patients, six had relapsing-remitting (RR), five relapsing progressive (RP), and twenty-six chronic progressive (CP) disease patterns. For all groups combined, significant improvements between admission and discharge were seen in FIM (p = .0001), FS (p = .0001), and EDSS (p = .0001) scores. Gains were partly maintained between discharge and follow-up. FS and FIM subscales were examined to ascertain which deficits were most amenable to rehabilitation therapies. Inpatient rehabilitation is associated with significant functional improvement for MS patients. Key Words: Multiple sclerosis&mdash;Neurorehabilitation.
The efficacy of inpatient rehabilitation in multiple sclerosis (MS) has not been well defined. The few published studies lend support to the notion that it is useful to offer intensive multidisciplinary programs (MDR) focused on reducing the impairments and disabilities associated with MS (1). There is no consensus regarding which problems are most amenable to MDR, how much better patients are because of such treatment, or how long improvements last. Because there is a prevailing belief that MS patients do benefit from trcattnent for exacerL,ations, prospective studies with controls studying the effects of MDR are almost impossible in this population. Although not optimal, retrospective reviews are often the only means available to investigate these issues.
Even before the current emphasis on cost containment, rehabilitation leaders advised caution in the allocation of limited resources to MS treatment because of the progressive nature of the disease (2) . Recent stud-ies that did attribute substantial benefit to MDR in MS have reported exacerbations during the study period, leaving unresolved the question of whether the degree of benefit merits the effort (3) . Nonetheless, at least in selected patients, the beneficial effects may justify MDR, particularly if a &dquo;refresher&dquo; is permitted on a periodic basis (1) .
In this retrospective study we examined the impact of inpatient MDR on the impairments and disabilities associated with MS. The influence of MS &dquo;type&dquo; [relapsing-remitting (RR), relapsing progressive (RP), and chronic progressive (CP)], major impairment(s), and duration of improvement were also studied.
Methods
Retrospective chart reviews were conducted on all (n = 37) consecutive MS patients admitted to the Burke Rehabilitation Hospital over a two-year period (1992) (1993) (1994) . Patients were referred for rehabilitation following functional decline related to disease activity, trauma, surgery, or systemic illness. The patients were admitted either from home (often having failed outpatient interventions) or from acute care. The degree of functional decline necessitating inpatient referral was defined on an individual basis by the patient's community physician. Each patient was enrolled in a 2-5 hour/day rehabilitation program designed to treat their specific deficits. All patients received individualized physical therapy (stretching, strengthening, ambulation training, transfer training) and occupational therapy (functional upper limb exercises, adaptive equipment, community skills training, daily living skills). Depending on the patient's needs, speech therapy (dysphagia assessment and managemcnt, articulation strategies, cognitive stimulation, memory training), recreational therapy, and group physical and occupational therapy were provided. Impairments amenable to pharmacotherapy such as spasticity, neurogenic bowel and bladder, pain, and tremor were treated by the attending neurologist. Bladder catheterization and other self-care skills were taught to patients and caregivers by the nursing staff.
Demographic information, MS type, reason for admission, Functional Independence Measurement (FIM) scores, and Functional Systems (FS) and Expanded Disability Status Scale (EDSS) scores were recorded for each patient (4, 5) . The FS subscores were summed to give a quantitative impairment score.
Two sets of follow-up FIM and EDSS data were obtained from most patients during telephone interviews conducted at two points in time unrelated to patients' clinical status or date of original admission (six to thirtysix months after discharge). Interviews were conducted at the time of the initial chart review and repeated approximately nine months later. The interview was conducted by trained research assistants, who were blinded as to disease type and prior functional status. Previous studies have shown that patient self-reporting of global neurologic impairment by EDSS can closely approximate physician ratings (6) . FIM data was obtained using the standard telephone Follow-up FIM Assessment form published hy Uniform Data Systems for Medical Rehabilitation (4).
Statistical analysis was performed with the Statview II statistical software program on a Macintosh II computer. One-factor analysis of variance (ANOVA) was used to examine the relationships between baseline, discharge, and follow-up neurological impairments (FS total score and individual FS subscores) and disabilities (FIM and EDSS total scores and subscores).
Results
Of the thirty-seven patients studied, four were male and thirty-three female with a mean age of 46.87 (SD 11.275, range 24-68). The mean time since diagnosis was 11.84 years (SD 8.73, range 0.1-32 years). Twenty-six out of thirty-seven had CP, six had RR, and five had RP disease patterns. The average length of stay was thirty-two days (SD 15.03, range 12-77 days); the patients requiring more than six weeks of rehabilitation generally had suffered severe exacerbations with new major impairments or MS exacerbations associated with a surgical procedure. Such patients often required major (structural or social) changes in the home environment, as well as intensive multidisciplinary care to help overcome new disability.
For all patients combined, statistically significant improvements between admission and discharge mean FIM (admission = 85.25, discharge = 96.43, p = .0001), EDSS (admission -7.47, discharge = 6.92, p = .0001 ), and FS (admission = 14.73, discharge = 13.00, p = .0001) scores were found. These improvements were apparent irrespective of disease pattern, although EDSS and FS changes did not achieve significance in RR and RP groups, probably due to the small sample size.
Significant improvements also occurred in FIM subgroupings : self-care (eating, dressing, grooming, bathing) (p = .0001 ), sphincter control (bladder, bowel) (p = .0222 ), and locomotion (ambulation, stair climbing, wheelchair management) (p = .0001) for all patients combined, as summarized in Table 1 . The must striking increases in level of independence occurred in self-care (81 percent of patients improved), and the least in sphincter control (32.43 percent improved).
To determine which underlying physical impairments were most amenable to rehabilitation therapy, pyramidal, cerebellar, bowel/bladder, and sensory FS subgroup changes were individually examined. The most significant (p = .0001) change occurred in pyramidal function, with an improvement in mean score from 3.49 (out of a maximum of 6) (SD 1.407) to 2.81 (SD 1.39) between admission and discharge. Significant though smaller improvements were seen in cerebellar function (p = .0033) and sphincter control (p = .048). Minor improvement in sensory function did not reach statistical significance.
To determine whether a specific major impairment predicted response or failure to rehabilitation, patients with individual FS subscores greater than 3 were contrasted with those with lower subscores. No significant effect was found for any neurologic symptom.
Patients received one or two follow-up telephone assessments at intervals ranging from six months to three years after discharge to determine how long improvements in disability and impairment were sustained. Seventeen patients had follow-up at six to twelve months after discharge and showed no significant change in mean FIM (d/c: 94.9 ± 14.21, f/u 94.8 ± 24.94, p = .98) or mean summed FS (d/c: 11.8 ± 3.98, f/u: 11.6 ± 5.0, p = .53).
Follow-up assessments obtained in twenty-eight patients at twelve to twenty-four months showed statistically insignificant changes in FIM (d/c: 100.1 ± 15.97, f/u: 95.6 ± 26.15, p = .22), and FS status (d/c: 12.4 ± 4.59, 13.7 ± 5.91, p = .12). Twelve patients were assessed twenty-four to thirtysix months after discharge and showed no significant changc in FS (d/c: 14 ± 5 .33, f/u: 13.5 ± 7.04, p = .76), but FIM performance did significantly deteriorate (d/c: 98.5 ± 19.54, f/u: 88.83 ± 30.84, p = .008). FIM functional subscores were individually examined and showed the only significant decline in performance to be in locomotion status at three years (p = .0133).
Discussion
Although advances in immunosuppressive therapy promise to slow central demyelination, progressive disability continues to be the characteristic experience of MS patients. By drawing on multidisciplinary resources to treat manifestations of the disease, clinicians may enable patients to function more independently for a longer time. Inpatient rehabilitation provides a structured &dquo;package&dquo; of such services delivered in an intensive manner. It is necessary to determine whether this mode of treatment is effective enough to justify the effort it requires.
A prior study by Feigenson and colleagues that addressed both of these issues suggested that inpatient MS treatment is heneficial (7) . Twenty MS patients with longstanding disability refractory to outpatient rehabilitation efforts were admitted for an average of 52.5 days of MDR. Significant functional benefits were realized in balance, self-care, bladder management, bed mobility, and wheelchair management. The only neurologic improvement was a reduction in cerebellar symptoms, which was not statistically significant. Interestingly, therapy failed to improve muscle strength or decrease spasticity, despite the prevailing view that pyramidal dysfunction is ameliorated by sustained stretching and judicious strengthening (8) (9) (10) . During phone surveys conducted one year later, patients indicated that the functional gains were maintained and that home care costs were substantially reduced as a result.
In one of the few prospective studies published, inpatient MDR was compared to outpatient trcatment in eighty-four patients (11) . MDR was provided for an average of twenty-one days, and assessments were performed prior to admission and (by interview by a nurse) at three-month intervals for one year after discharge. The outcome measures were disability, as reflected by the Incapacity Status Scale (a self-report inventory), and hours of home care required (12) . Significant but mod-est decreases in disability were seen in the inpatient group at three months after discharge; by twelve months no differences were apparent. No impact on home care was found.
A large retrospective multicenter study examined the functional impact of inpatient MDR in 196 MS patients and again showed small but significant declines in disability ( 13) . Impairment was not assessed and latc followup data were not obtained.
Our study differs from previous studies. The influence of rehabilitation on specific neurologic impairments was expired in addition to disability. The influence of MS disease pattcrn and primary neurologic symptoms on rehabilitation outcomes were also examine. The data reflect a substantially longer follow-up period.
Like previous studies, our findings indicate that inpatient MDR objectively decreases disability in MS patients. Additionally, statistically significant improvement in three areas of neurological impairment was seen. Cerebellar dysfunction declined. Although Feigenson's study suggested that ataxia and incoordination may be responsive to MDR, these symptoms are generally felt to be unresponsive to conventional rehabilitation techniques; because cerebellar symptoms can be disabling, a broad range of investigational techniques for their treatment have been proposed (8, (14) (15) (16) (17) . The relative success our program demonstrated may reflect an aggressive approach that combines pharmacotherapy, such as benzodiazepines and other sedative hypnotic agents, with balance and coordination training.
Pyramidal function improved, probably retlecting selective strengthening of muscles innervated by less involved pathways and the effects of stretching/pharmacotherapy on spasticity (8, 10) .
Although sphincter control also improved significantly, bladder dysfunction was less responsive to MDR than were other symptoms. This was the case despite wellestablished guidelines for neurogenic bladder management and a general emphasis in the literature on the responsiveness of this symptom to aggressive treatment (9, 15) . Reasons for this may include the greater degree of baseline disability present in the population referred for inpatient MDR and the resultant difficulty mastering selfcatheterization or tolerating anticholinergic drugs.
The presence of profound focal neurologic dysfunction did not preclude benefit from MDR, and disease pattern was not an important predictor of response.
This retrospective study suggests that inpatient MDR results in a sustained reduction in disability and neurological impairment in MS patients with moderate to severe disease, regardless of disease &dquo;type&dquo; or primary disabling symptom. This enables patients to remain func, tional and more independent.
